Research Paper Volume 16, Issue 2 pp 1516—1535
Molecular map of cGAS-STING pathway-related genes in bladder cancer: the perspective toward immune microenvironment and prognosis
Figure 8. Correlation of the risk score with immunotherapy response in two cohorts. Survival analyses (A), Distribution of risk score in different immunotherapy response groups (B), and Response to anti-PD-L1 therapy (C) between low- and high-risk groups in advanced urothelial cancer cohort (IMvigor210 cohort). Survival analyses (D), Distribution of risk score in different immunotherapy response groups (E), and Response to anti-PD-1 therapy (F) between low- and high-risk groups in melanoma cohort (GSE78220). (G–I) Differences in IPS and TIDE among individuals categorized as high- and low-risk.